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ABSTRACT 
Introduction: Thoracic paravertebral block (PVB) block is frequently used in breast cancer surgery for postoperative 
pain management. Adding opioids to local anaesthetics has been shown to have beneficial effects during epidural anal- 
gesia. Our hypothesis was that adding morphine to bupivacaine for PVB would improve analgesia provided by this 
procedure. Methods: 60 patients (25 - 75 years) undergoing elective surgery for breast cancer were randomly assigned 
to one of two groups. Both groups received a single injection thoracic paravertebral block; group BAM with 20 ml 0.5% 
bupiva- caine, epinephrine and morphine while group BA received identical block except morphine was given subcuta-
neously. All patients had general anaesthesia. Results: Severity of pain and nausea was low in both groups. Pain scores 
remained below 20/100 after the first 2 hours throughout the 72 hours of the study. There was no significant difference 
between the groups in pain scores, consumption of additional morphine or nausea scores. Shoulder mobility was also 
very good in both groups. Conclusion: Thoracic paravertebral block with bupivacaine and epinephrine was associated 
with good postoperative analgesic effects and low incidence of nausea and vomiting. The addition of morphine to the 
local anaesthetic solution in paravertebral block did not have any additional analgesic effects. 
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1. Introduction 
Traditionally breast cancer surgery has been performed 
under general anaesthesia. However, it has been associ- 
ated with troublesome postoperative pain as well as high 
incidence of nausea and vomiting. During recent years 
paravertebral nerve block has been suggested as an at- 
tractive alternative for this type of surgery, providing 
adequate pain relief and a reduced incidence of postop- 
erative nausea and vomiting [1-3].  
In most clinical trials on paravertebral nerve block the 
local anaesthetics bupivacaine or ropivacaine have been 
used alone [1-5]. During postoperative pain management 
with continuous epidural analgesia, however, addition of 
epinephrine and opioids has been shown to significantly 
improve intensity of the block [6-9].  
Our hypothesis was that adding morphine to bupiva-
caine and epinephrine would improve the quality of pa- 
ravertebral blockade during breast cancer surgery. The 
effect on postoperative pain intensity and morphine con- 
sumption was studied as a primary outcome. Nausea and 
vomiting and number of patients receiving antiemetic me- 
dication as well as hospital stay were secondary outcome 
measures. 
2. Methods 
After institutional ethics committee approval of the study 
protocol and written informed consent, 60 patients (ASA 
I-II), aged 25 to 75 years, undergoing elective surgery for 
cancer of the breast were entered into this prospective 
double blind clinical trial. They underwent either uni- 
lateral wedge resection with exploration of the axilla or 
unilateral mastectomy with exploration of the axilla. The 
minimum hospital follow-up time was 24 hours. Patient 
exclusion criteria included coagulation disorder, infec- 
tion at the site of blockade and a history of adverse reac- 
tion to local anaesthetics or morphine, morbid obesity, 
current medication with opioids, age over 75 years, sig- 
nificant cardiopulmonary disease, and history of severe 
PONV.  
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Patients were randomly assigned into one of two 
groups. Group BA received thoracic paravertebral block 
(PVB) with a single injection at T3 using 20 ml 0.5% 
bupivacaine, epinephrine 5 μg/ml and 0.4 ml isotonic 
saline. In addition they received a subcutaneous injection 
of morphine 10 mg/ml 0.4 ml. The other group (group 
BAM) received PVB using 20 ml 0.5% bupivacaine and 
fresh epinephrine 5 μg/ml as in group BA, but unlike 
group BA, group BAM also received paravertebral mor- 
phine, 0.4 ml (10 mg/ml) and a subcutaneous injection of 
isotonic saline 0.4 ml.  
Before surgery the patients were enrolled to one of two 
groups using a list of random numbers, generated by a 
computer, in sealed envelopes. The randomization pro- 
cess was in the hands of pharmacists of the hospital phar- 
macy who provided the study drugs in syringes ready for 
injection. Two experienced anaesthesiologists performed 
all the blocks. The physician providing the PVB was 
blinded to the content of the local anaesthetic and subcu- 
taneous solutions. Before performing the PVB the pa- 
tients were sedated in a sitting position by administering 
1.0 - 2.5 mg of midazolam intravenously (i.v.). The block 
was performed using the technique described by Eason 
and Wyatt [10] using a 25 gauge, 9 cm Quincke spinal 
needle (Braun, Spinocan, Melsungen, Germany). The 
spinal needle with a depth marker was introduced at 90˚ 
to the skin in all planes 2.5 cm lateral to the anatomical 
midline at the cephalad end of the spinous process of the 
3rd thoracic vertebra and advanced to strike the rib or 
transverse process of the vertebra below. When bone 
contact was reached, the needle was withdrawn to the 
subcutaneous tissue and redirected cephalad to pass 
above the transverse process or the rib and then advanced 
further 1.0 - 1.5 cm. After careful aspiration the 20.5 ml 
of drug mixture (bupivacaine, epinephrine and isotonic 
saline in group BA and bupivacaine, epinephrine and 
morphine in group BAM) was administered into the pa- 
ravertebral space. Injection time was 1 - 2 minutes. Effi- 
cacy of the PVB was assessed by loss of sensibility to 
cold using ethyl chloride spray and to pin prick over the 
involved dermatomes at least 10 min after completion of 
the block. 
Following completion of the blockade all patients re- 
ceived general anaesthesia with propofol 2 - 3 mg/kg i.v. 
and fentanyl 0.3 - 0.6 µg/kg i.v. A laryngeal mask airway 
(LMA) was inserted and anaesthesia was maintained 
with sevoflurane and nitrous oxide in oxygen and spon- 
taneous breathing. Fentanyl 0.3 - 0.6 µg/kg was adminis- 
tered as deemed necessary by the attending anaesthesi- 
ologist. All patients received paracetamol 1 g rectally im- 
mediately after start of general anaesthesia and post- 
operatively 1 g of paracetamol orally or rectally every six 
hours for at least 24 h. All patients were treated with on- 
dansetron 4 mg i.v. about 20 min before the end of the 
operation for prevention of nausea. 
Procedural data were recorded including time for 
placement of PVB, start and end of general anaesthesia 
as well as the surgical procedure. The total intraoperative 
fentanyl dose administered to each patient was recorded. 
In the postoperative care unit all patients were con- 
nected to an i.v. PCA pump containing morphine with a 
dose of 1 mg, with 10 min lockout period. Nurses in the 
postoperative care unit were instructed to give rescue 
doses of morphine, 2 mg i.v. as they deemed necessary. 
Visual analog scale (VAS) pain scores were recorded 
at 30 min, 60 min, 2 h, 6 h, 24 h, 48 h and 72 h on a 100- 
mm scale (0 mm = no pain to 100 mm = worst pain ima- 
ginable). Nausea was measured by a comparable VAS (0 
mm = no nausea to 100 mm = vomiting) at the same time 
points. Ondansetron 4 mg i.v. was administered when- 
ever a patient’s nausea score was higher than 30 mm. 
Patients that were discharged from the hospital recorded 
their scores on standardized forms with two 100 mm 
visual analog scales at 48 and 72 h and submitted by mail. 
Postoperative painful restricted movement of arm, classi- 
fied into three grades (restricted, fair and free; free 
meaning able to put the hand behind the head and fair 
meaning abduction to 90 degrees without discomfort) 
was recorded at 30 min, 60 min, 2 h, 6 h and 24 h. Post- 
operative assessments were made by an observer blinded 
to the study medication (i.e. local anaesthetic/morphine 
solution and peroperative analgesic requirements). Post- 
operative PCA consumption of morphine was recorded 
as well as antiemetic requirements. Hospital stay was 
measured from the time of arrival to the recovery room 
until the time when the patient left the hospital, which 
was decided by the surgeon in charge. 
Descriptive statistics for demographics, procedural da- 
ta and intraoperative opioid administration were produced. 
Pain and nausea scores, restriction of movement as well 
as PCA morphine consumption and antiemetic require- 
ments were analysed. In a pilot study the response within 
each subject group was normally distributed with stan- 
dard deviation of 12. We decided that a clinically sig- 
nificant difference in the experimental and control mean 
pain scores would be 10. Sample size calculation based 
on that suggested we would need to study 24 experimen- 
tal subjects and 24 control subjects to be able to reject the 
null hypothesis that the population means of the experi- 
mental and control groups are equal with probability 
(power) 0.8 [11]. The Type I error probability associated 
with this test of this null hypothesis is 0.05. 
We decided to include 60 patients (30 in each group) 
to have a margin for uncertainty of the estimated stan- 
dard deviation and possible dropouts. A two-tailed t-test 
was used for comparison of the two groups. 
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3. Results 
54 women completed the whole study protocol. Two 
were excluded, one because of error in the preparation of 
the local anaesthetic and the other because the operation 
was terminated as a result of unexpected histopathologic 
finding. One patient had a reoperation at 32 hours due to 
bleeding that started between 6 and 24 hours and only the 
scores for the first 6 hours were used. Three did not re- 
turn the form for pain and nausea score at 48 and 72 
hours. Their scores for the first 24 hours were entered in 
the statistical analysis. Thus values from 58 patients were 
analysed (Figure 1). During general anaesthesia low sys- 
tolic blood pressure was often registered requiring occa- 
sional intravenous doses of ephedrine but no serious side 
effects of the paravertebral block were noted in any of 
the patients throughout the study. Preoperative assess- 
ments of the block revealed that there was considerable 
variation in spread of anaesthesia but none was judged as 
failed block. The number of blocked segments in each 
group is shown in Table 1.  
31 patients received PVB with bupivacaine, epineph- 
rine and morphine and a subcutaneous injection of saline 
(BAM) while 29 patients received PVB with bupivacaine 
and epinephrine and a subcutaneous injection of mor- 
phine (BA). 
Analysis of demographic data revealed that the study 
groups were identical (Table 2). The ratio between mas- 
tectomy and wedge resection was 15/16 respectively in 
the BAM group and 11/16 in the BA group. 
After the first two hours the VAS pain scores remained 
below 20 mm and there was no significant difference in 
 
 
Figure 1. Enrollment of patients. 
pain score between the two main groups (Figure 2). The 
amount of fentanyl given during the operation was equal 
in both groups. There was no difference in morphine 
consumption between the groups, neither PCA adminis- 
tered nor total consumption (Table 3).  
The nausea scores on the predefined time points for 
observation were low and no significant difference in 
nausea score between the groups (Figure 3). Only 4 out 
of 31 in the BAM group and 1 out of 27 in the BA group 
scored 30/100 mm or higher on the visual analog scale 
for nausea at some time point during the observation pe- 
riod. However, seven patients in the BAM group re-
ceived antiemetic medication. Sometime during the first 
24 hours postoperatively compared with 12 patients in 
the BA group (ns). 
Shoulder mobility was excellent, i.e. free, in at least 
50% of patients in the BAM group throughout the first 
24 hours postoperatively (Figure 4(a)). In the BA group 
this fraction was between 40% and 50% at 30 min and 6  
 
 
Figure 2. Comparison of average visual analog pain scores 
during the first 72 hours postoperatively. Group BAM re- 
ceived bupivacaine, epinephrine and morphine into the pa- 
ravertebral space and subcutaneous saline. Group BA re- 
ceived bupivacaine, epinephrine and saline into the para- 
vertebral space and subcutaneous morphine. There was no 
statistical difference between the groups. Observe that from 
two hours postoperatively the pain score remained below 
20/100 throughout the study. 
 
Table 1. Number of blocked segments. 
Group BAM BA 
Number of anaesthetized  
segments, cold, median (range). 6 (0 - 15) 7 (4 - 14) N.S. 
Number of anaesthetized  
segments, pinprick median (range). 4 (2 - 10) 5 (2 - 11) N.S. 
Assessment of sensibility to cold and pinprick. Group BAM received para- 
vertebral block with a solution containing bupivacaine, epinephrine and mor- 
phine while group BA got paravertebral block with bupivacaine and epi- 
nephrine and subcutaneous morphine. There was no significant difference in 
number of blocked segments. 
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Table 2. Demographic characteristics of 58 patients includ- 
ed in data analysis. 
Variable/groups BAM BA 
Age (year; mean ± SD) 54.6 ± 10.1 53.5 ± 11.0 
Height (cm; mean ± SD) 166.6 ± 4.5 167.8 ± 5.0 
Weight (kg; mean ± SD) 71.8 ± 12.4 72.4 ± 10.7 
Surgical procedure mastectomy 
and axillaryexploration, number 
Wedge resection and axillary 
exploration, number 
15 
16 
11 
16 
Duration of surgery  
(min; mean ± SD) 79.9 ± 15.3 80.5 ± 20.1 
Group BAM received paravertebral block with a solution containing bu- 
pivacaine, epinephrine and morphine while group BA got paravertebral 
block with bupivacaine and epinephrine and subcutaneous morphine. There 
was no statistical difference between the groups in any of the parameters pre- 
sented. 
 
Table 3. Morphine consumption in the first 24 hours. 
Variable/group BAM BA 
PCA morphine consumption, 
mg; mean ± SD 14.8 ± 11.2 13.7 ± 10.4 
Total morphine  
consumption, mg; mean ± SD 16.9 ± 12.8 16.1 ± 12.6 
Peroperative fentanyl  
administration, µg; mean ± SD 83.9 ± 34.3 77.4 ± 32.6 
Group BAM received paravertebral block with a solution containing bu- 
pivacaine, epinephrine and morphine while group BA got paravertebral 
block with bupivacaine and epinephrine and subcutaneous morphine. Total 
morphine consumption represents PCA morphine consumption plus nurse 
controlled rescue doses. There was no statistical difference between the 
groups in any of the parameters. 
 
 
Figure 3. VAS scores for nausea. Group BAM received bu- 
pivacaine, epinephrine and morphine into the paravertebral 
space and subcutaneous saline. Group BA received bupiva- 
caine, epinephrine and saline into the paravertebral space 
and subcutaneous morphine. 7 out of 30 patients in the BAM 
group received antiemetic postoperatively compared with 
12 out of 27 in the BA group. 
 
hours and at the other time points it was 50% or greater 
(Figure 4(b)). Patients assessed as having free or fair 
mobility at any of the given time points were ≥90% in 
both groups. 
The mean hospital stay for both groups was 47 ± 14.7 
hours and there was no significant difference between the 
groups (Table 4). 
4. Discussion 
The results of this study do not confirm the hypothesis, 
that adding morphine to bupivacaine for paravertebral 
block (PVB) would improve the analgesia provided by 
this procedure. However, the pain scores were very low 
in both groups after the first 2 hours. In fact they did re- 
main below 20 mm throughout the 72 hours of the study, 
which is generally accepted as very good. The PONV 
score was also good in both groups as well as sholder 
 
 
(a) 
 
(b) 
Figure 4. (a) Estimated restriction of movement in the 
shoulder joint by pain classified into three grades (restric- 
ted, fair and free; free meaning able to put the hand behind 
the head and fair meaning abduction to 90 degrees without 
discomfort) in the group receiving paravertebral bupiva- 
caine, epinephrine and morphine and subcutaneous saline. 
(b) Estimated restriction of movement in the shoulder joint 
by pain classified into three grades (restricted, fair and free; 
fair meaning abduction to 90 degrees without discomfort) in 
the group receiving paravertebral bupivacaine, epinephrine 
and saline and subcutaneous morphine. 
 
Table 4. Hospital stay (hours). 
Group N Mean ± SD Minimum Maximum 
BA 
BAM 
Total 
27
31
58
49 ± 16 
46 ± 11 
47 ± 13 
22 
20 
20 
100 
74 
100 
Group BA received paravertebral block with bupivacaine and epinephrine 
and subcutaneous morphine while the BAM group received paravertebral 
block with bupivacaine, epinephrine and morphine. SD = Standard deviation. 
There was no statistical difference in hospital stay between the groups. 
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mobility. These results suggest that paravertebral block 
with bupivacaine and epinephrine, with or without mor- 
phine offers efficient postoperative pain relief after breast 
cancer sugery.  
In previous studies the efficiency of PVB in providing 
analgesia after surgery for cancer of the breast has been 
shown to be superior to traditional analgesic regimens. 
Therefore the present study was designed to have only 
two groups i.e. a treatment group and a control group but 
not a second control group with a sham PVB. Although 
techniques that employ multiple segmental blocks are 
known to give more complete analgesia than a single in- 
jection approach we did not consider it worthwhile or 
even ethical to put our patients through such an extensive 
procedure for postoperative analgesia bearing in mind 
that all were going to have general anaesthesia nonethe- 
less. 
The VAS pain scores were similar in both groups as 
was morphine consumption. The PCA dose of 1 mg mor- 
phine with a lockout period of 10 min proved to be too 
small for many patients in the first postoperative hour 
and nurse controlled rescue doses had to be given during 
that time but rarely later. In general the pain scores and 
opioid consumption in this study population was low. 
One might argue that using 0.5% bupivacaine produced 
too powerful analgesia for the possible subtle effect of 
morphine to be detected. However, using a weaker solu- 
tion on those thoracal segments would not have brought 
any advantage. With the long effect of perispinal mor- 
phine in mind one could speculate that a difference in 
analgesia might be seen when the effect of the local anes- 
thetic was waning. This was not the case. 
The pain scores were very low in both goups after the 
first 2 hours and we did not see a tendency to a diffe- 
rence between the groups at any time. It is therefore un- 
likely that a larger sample size would have detected a 
clinically significant difference provided the same me- 
thods protocol was used. 
The decision to exclude patients with history of ex- 
treme PONV was made after encountering such patients 
in a pilot study where it proved to be extremely difficult 
to obtain reliable pain scores. We were mainly interested 
in finding out if the paravertebral route of administration 
for morphine was associated with more nausea than the 
subcutaneous route. The incidence of significant nausea 
turned out to be low in both groups. More patients in the 
BAM group scored 30/100 mm or higher for nausea at 
some time point compared to the patients of the BA 
group who on the other hand received more doses of an- 
tiemetic drugs. We can state that the paravertebral route 
of administration of morphine was not associated with 
increased nausea. 
We did not expect to see a difference in shoulder 
mobility on the grounds that opioids are mainly effective 
for pain at rest and less so for pain on movement. Our 
results agree with that as shoulder mobility was fair to 
excellent in the vast majority of patients in both groups. 
Epinephrine has been shown to increase sensory block 
and improve the analgesic effect of a mixture og bupi- 
vacaine and fentanyl when given epidurally [7]. The in- 
fluence of epinephrine on the pain relieving effect of 
perispinal morphine has been more equivocal. We decid- 
ed to include epinephrine in order to delay the uptake of 
morphine into the systemic circulation and thus facilitate 
penetration into the spinal nerves. 
In conclusion thoracic paravertebral block with bupi- 
vacain and epinephrine appears to be safe and efficient 
way of providing postoperative analgesia for breast can- 
cer surgery. Adding 4 mg of morphine to the local anaes- 
thetic solution does not bring additional benefit but does 
not seem to do any harm either. It does not affect nausea 
or duration of hospital stay. 
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